Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of LND101001 in mild to moderate Alzheimer's disease
2013-001851-11Phase 2Completed
- Sponsor
- Lupin Atlantis Holdings
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of edonerpic in Alzheimer's disease (AD) (3 arms), sponsored by Lupin Atlantis Holdings. Started Aug 2013; status: completed.
02
Drugs
edonerpic
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2013-001851-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001851-11.